Bank Of America Raises Lakefront Biotherapeutics Stake Above To 10.11%

Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) received a transparency notification from Bank of America.

Pursuant to Belgian transparency legislation1, Lakefront received a transparency notification from Bank of America Corporation on August 19, 2026. The notification indicates that Bank of America Corporation, as controlling entity, crossed above the threshold of 10% of Lakefront’ voting rights on August 18, 2026, following the acquisition of Lakefront voting rights and equivalent financial instruments.

On August 19, 2026, Bank of America Corporation (taking into account the holding of its affiliates) owned 1,419,144 voting rights and 5,243,453 equivalent financial instruments, representing together 10.11% of Lakefront’ currently outstanding 65,897,071 shares.

Summary of the transactions:

Content of the notification from Bank of America Corporation:

The notification dated August 19, 2026, contains the following information:


•        Date of notification: August 19, 2026


•        Date on which the threshold is crossed: August 18, 2026


•        Threshold of voting rights crossed (in %): 10%


•        Notification by: Bank of America Corporation


•        Denominator: 65,897,071


•        Reason for the notification: Acquisition or disposal of financial instruments that are treated as voting securities


•        Notified details: